FDA Warns of Pradaxa® Bleeding and Death Risk–Koester & Bradley is pursuing Pradaxa Cases in Champaign-Urbana and CentralIllinois.
The anticoagulant Pradaxa® (generic: dabigatran) has been reported to cause injuries such as:
- Death
- Brain Hemorrhaging
- Kidney Bleeding
- Gastrointestinal (GI) Bleeding
- General Internal Bleeding
- Heart Attack/ Cardiac Injury
Source: US Food and DrugAdministration.
In a recent press release, the manufacturer of Pradaxa® , Boehringer Ingelheim Pharmaceuticals , admitted that Pradaxa ® had caused at least 260 deaths from excessive bleeding. Source:
Lawsuits have been filed on behalf of Pradaxa ® victims since 2012 in Courts across the country. Most of these suits are alleging thatPradaxa ® marketing and design defects have caused life-threateningbleeding. Lawsuits also allege that Boehringer Ingelheim Pharmaceuticals failed to warn physicians andpatients adequately of the risks associated with taking Pradaxa ® . (read more)
